Search results for: 'belt areas'

The low-power wide area network (LPWAN) market is in a growth stage, with network operators collaborating to establish LPWAN standard convergence. While some LPWAN providers are arranging deals to combine LoRaWAN with Sigfox in their connectivity offerings, others are integrating proprietary LPWAN with cellular LPWAN. LPWAN providers are also ...

Low-power wide-area networks (LPWANs) are gaining traction globally for their extended coverage, low transmission rate, long battery life, and beneficial cost savings in operations, capabilities that are determinantal to enabling massive machine-to-machine (M2M) and Internet of Things (IoT) deployment for non-mission critical applications. Custo...

This research service details the market findings witnessed in the North American aftermarket for belts, hoses, gaskets, and seals.

This report provides an overview of the North American (Canada and the United States) aftermarket for automotive belts, hoses, gaskets, and seals. Performed through extensive primary and secondary research, this report forecasts how the aftermarket for these products will grow over the next 6 years. Quantitative analysis brings to light revenue f...

22 Aug 2016  |  North America  |  Market Research

Automotive Industry IT Spending—CIO Focus, Trends, and Highest Growth Areas

By 2020, IT Spending by Automotive Companies to Reach $80.05 Billion

Infographics

×

Growing digitization, connectivity, cloud computing, dynamic customer preferences, Internet of Things (IoT), cybersecurity, and increasing automation are the key trends driving the automotive industry to invest in IT. Automotive OEMs, Tier I suppliers, and automotive ecosystem participants invest in key focus areas including Industry 4.0, digital r...

23 Oct 2020  |  North America  |  Market Research

Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026

Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities

Infographics

×

Key Issues Addressed

In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...

09 Nov 2020  |  North America  |  Market Research

Industry Convergence and Disruptive Technologies are Key Growth Areas of the Global Shared Mobility Market, 2030

Future Growth Potential Enhanced by Opportunities in Mobility-as-a-Service and Autonomous Technologies

Infographics

×

Key Issues Addressed

In the last decade, there has been rapid progress towards a new paradigm for transporting people in cities. Driven by quickly evolving technologies, new business models, and shifting societal expectations, mobility has become more sustainable, equitable, efficient, and convenient. However, the recent COVID-19 pandemic has disrupted the global mobil...

28 Jan 2022  |  North America  |  Market Research

Global Low-Power Wide-Area Networks (LPWAN) Market, Forecast to 2025

LPWAN Technologies to Shape the Future of Massive IoT, Allowing Many Use Cases to Scale

Infographics

×

Low power wide area network (LPWAN) is a wireless wide area network that is optimized for non-mission-critical applications in machine-to-machine (M2M) and Internet of Things (IoT) communications. LPWAN deployments benefit M2M and IoT applications in terms of extended coverage, low transmission rate, longer battery life, cost savings in operations,...

31 May 2022  |  North America  |  Market Research

Global RNA Therapeutics Growth Opportunities

Future Growth Potential Driven by Co-Development Programs and Robust Clinical Trials for Diverse Disease Areas

Infographics

×

Scientific advancements in nucleic acid-based therapies have significantly impacted the global biopharmaceutical industry. The ribonucleic acid (RNA) therapeutics market is expected to witness remarkable clinical progress as therapies target “undruggable” pathways. Technologically advanced platforms are integrated into RNA therapeutics bioprocessin...